Treatment of advanced prostatic cancer with LHRH analogue ICI 118630: clinical response and hormonal mechanisms

9 of 12 patients with advanced metastatic carcinoma of the prostate treated with luteinising-hormone-releasing-hormone (LHRH) analogue ICI 118630 for a mean period of 6 months showed objective evidence of response to treatment. Of 8 patients with bone pain, 7 obtained relief. After 6 weeks of treatm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1983-08, Vol.2 (8347), p.415-419
Hauptverfasser:	Ahmed, S R, Brooman, P J, Shalet, S M, Howell, A, Blacklock, N J, Rickards, D
Format:	Artikel
Sprache:	eng
Schlagworte:	Acid Phosphatase - blood Aged Bone Neoplasms - drug therapy Bone Neoplasms - secondary Chorionic Gonadotropin - metabolism Depression, Chemical Gonadotropin-Releasing Hormone - analogs & derivatives Gonadotropin-Releasing Hormone - therapeutic use Goserelin Humans Lymphatic Metastasis Male Middle Aged Pain - drug therapy Pelvis - diagnostic imaging Prostatic Neoplasms - drug therapy Radiography Testosterone - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!